A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities
- 作者Yiming Chen; Hagop Kantarjian; Zeev Estrov; Stefan Faderl; Farhad Ravandi; Kristy Rey; Jorge Cortes; Gautam Borthakur
- 卷第12卷
- 期第5期
- 文件大小213.69KB
- 发表时间2012
- DOI10.1016/j.clml.2012.04.001
同作者推荐
Complexity of BCR-ABL kinase domain mutations during the course of therapy with tyrosine kinase inhibitors in chronic myeloid leukemiaDushyant Verma; Carmen Fava; Hagop Kantarjian; Jorge Cortes · 2009
Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemiaFabio P. S. Santos; Hagop Kantarjian; Carmen Fava; Susan O’Brien; Guillermo Garcia-Manero; Farhad Ravandi; William Wierda; Deborah Thomas; Jianquin Shan; Jorge Cortes · 2010